Panagora Asset Management Inc. Acquires New Holdings in Corteva (NASDAQ:CTVA)

Share on StockTwits

Panagora Asset Management Inc. acquired a new stake in shares of Corteva (NASDAQ:CTVA) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 19,584 shares of the company’s stock, valued at approximately $579,000.

Other hedge funds have also modified their holdings of the company. Legacy Advisors LLC purchased a new position in Corteva during the second quarter valued at approximately $210,000. Gateway Investment Advisers LLC purchased a new position in Corteva during the second quarter valued at approximately $15,124,000. Bridge Creek Capital Management LLC purchased a new position in Corteva during the second quarter valued at approximately $5,559,000. Cardinal Capital Management purchased a new position in Corteva during the second quarter valued at approximately $709,000. Finally, Chemical Bank purchased a new position in Corteva during the second quarter valued at approximately $13,149,000.

In other Corteva news, Director Gregory R. Page bought 2,000 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were purchased at an average cost of $25.49 per share, with a total value of $50,980.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.

CTVA traded down $0.79 on Friday, reaching $29.50. 60,881 shares of the company’s stock were exchanged, compared to its average volume of 6,555,320. Corteva has a twelve month low of $24.35 and a twelve month high of $32.78. The business has a fifty day moving average price of $29.08.

Corteva (NASDAQ:CTVA) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $0.99 by $0.43. The company had revenue of $5.56 billion during the quarter, compared to analyst estimates of $5.47 billion. The business’s quarterly revenue was down 3.1% on a year-over-year basis.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Investors of record on Wednesday, July 31st will be paid a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a yield of 1.76%. The ex-dividend date of this dividend is Tuesday, July 30th.

Several equities analysts recently issued reports on the stock. Royal Bank of Canada raised shares of Corteva from a “sector perform” rating to an “outperform” rating and lifted their price objective for the company from $29.00 to $38.00 in a report on Friday, August 9th. SunTrust Banks started coverage on shares of Corteva in a research note on Monday, June 3rd. They issued a “hold” rating and a $29.00 target price for the company. Nomura started coverage on shares of Corteva in a research note on Monday, June 10th. They issued a “neutral” rating and a $28.00 target price for the company. Sanford C. Bernstein started coverage on shares of Corteva in a research note on Wednesday, June 5th. They issued a “market perform” rating and a $31.00 target price for the company. Finally, Goldman Sachs Group started coverage on shares of Corteva in a research note on Monday, June 3rd. They issued a “neutral” rating and a $29.00 target price for the company. One research analyst has rated the stock with a sell rating, eight have given a hold rating and eight have assigned a buy rating to the company’s stock. Corteva presently has a consensus rating of “Hold” and a consensus target price of $32.25.

Featured Article: Are all No-Load Funds Equal?

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva (NASDAQ:CTVA).

Institutional Ownership by Quarter for Corteva (NASDAQ:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Head-To-Head Review: Jerash Holdings   & Its Competitors
Head-To-Head Review: Jerash Holdings & Its Competitors
Analyzing Provectus Biopharmaceuticals  & Abbott Laboratories
Analyzing Provectus Biopharmaceuticals & Abbott Laboratories
Head to Head Comparison: Cyberark Software  vs. Red Violet
Head to Head Comparison: Cyberark Software vs. Red Violet
Ubiquiti  Cut to Hold at Zacks Investment Research
Ubiquiti Cut to Hold at Zacks Investment Research
Zacks Investment Research Lowers Stellus Capital Investment  to Sell
Zacks Investment Research Lowers Stellus Capital Investment to Sell
Playa Hotels & Resorts  Upgraded at Zacks Investment Research
Playa Hotels & Resorts Upgraded at Zacks Investment Research


 
© 2006-2019 Zolmax.